During the past decade, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 4 clinical trials were completed, i.e. on average, 16% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 1 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology" #1 sponsor was "Federal Research Institute of Pediatric Hematology, Oncology and Immunology" with 26 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Celgene" with 2 trials sponsored, "Shire" with 2 trials sponsored and "X4 Pharmaceuticals" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Physicians, Innovations, Science for Children Fund" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology" are "Childhood Acute Lymphoblastic Leukemia" (3 trials), "Wiskott-Aldrich Syndrome" (3 trials), "Chronic Granulomatous Disease" (2 trials), "Gaucher Disease, Type 1" (2 trials) and "Hematopoietic Stem Cell Transplantation" (2 trials). Many other conditions were trialed in "Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology" in a lesser frequency.

Most popular intervention types in "Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology" are "Drug" (20 trials), "Biological" (8 trials), "Other" (3 trials), "Diagnostic Test" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (4 trials), "Dexamethasone" (4 trials), "Bortezomib" (2 trials), "CD45RA-depleted peripheral blood mononuclear cells" (2 trials) and "Cytarabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology" are 35 trials for "All" genders.

Currently, there are NaN active trials in "Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, 4 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology has several departments that took part in Clinical trials: "National Medical Research Center for Children's Health" - 10 trials